COVID-19 Vaccine Indications for Patients Who Are Immunocompromised

Effective August 13, 2021, the Centers for Disease Control and Prevention (CDC) recommends that people who are moderately to severely immunocompromised receive an additional dose of an mRNA COVID-19 Vaccine (Pfizer-BioNTech or Moderna) at least 28 days after the completion of the initial mRNA COVID-19 vaccine series.

Frequently Asked Questions for Healthcare Providers

Page last reviewed: August 26, 2021